Table 3

Treatment and outcomes of the patients

PatientEyeType of ROP
(zone, stage)
PMA of first injection (weeks)Time from birth to first injection (weeks)Reactivation of ROPRegression of ridge after treatment (weeks)PMA of second injection or laser (weeks)Final outcomes (1*2*3*)Total follow-up time (weeks)
1OUI, 1+34+33+52226
2OUII, 3+33+66+439+6640240
3OUI, 1+3033230
4OUI, 3+33+55+22231
5OUII, 3+35+47+44236
6OUII, 3+32+45+21230
7OUII, 3+324+63228
8OUII, 3+33+23+638+4338+5342
9OUAP-ROP33+35+35230
10OUII, 3+30+65+137437+2338
11OUII, 2+356+51127
12OUII, 3+34+67+64230
13OUII, 2+35+573129
14OUII, 2+36+46+13126
15OUII, 2+36+26+52127
16OUII, 3+36+554228
17OD/OSII, 3+/ I, 3+33+176232
18OUII, 3+33+64+33229
19OUI, 2+35+34+34228
20OUII, 2+36+26+62130
21OUAP-ROP36+67+65232
22OUI, 3+37+27+24228
23OUII, 3+31+55+636+5636+6240
24OUII, 3+32+64+53127
  • Final outcomes: 1, full retinal vascularisation; 2, avascular area in zone III; 3, =retinal scar in zone II.

  • PMA, postmenstrual age; ROP, retinopathy of prematurity.